BioLeap Overview

  • Founded
  • 2004
  • Status
  • Acquired/​Merged
  • Employees
  • 4
  • Latest Deal Type
  • M&A

BioLeap General Information


Provider of drug designing services. The company identifies and optimizes lead compounds using its technology platform. It offers a proprietary technology platform to identify and optimize lead compounds to discover novel drugs.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 238 West Delaware Avenue
  • Pennington, NJ 08534
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioLeap Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jun-2015 00.00 Completed Profitable
4. Grant 18-Oct-2013 00000 00.00 Completed Profitable
3. Later Stage VC 05-Apr-2011 000 00.00 Completed Profitable
2. Early Stage VC (Series A) 12-Jan-2010 $5M $5.4M 000.00 Completed Profitable
1. Corporate 01-Jan-2009 $400K $400K Completed
To view BioLeap’s complete valuation and funding history, request access »

BioLeap Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view BioLeap’s complete cap table history, request access »

BioLeap Executive Team (4)

Name Title Board Seat Contact Info
Ian Cloudsdale Vice President, Chemistry
To view BioLeap’s complete executive team members history, request access »

BioLeap Board Members (6)

Name Representing Role Since
Anthony Ford-Hutchinson Ph.D Self Director 000 0000
You’re viewing 1 of 6 board members. Get the full list »

BioLeap Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioLeap Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adams Capital Management Venture Capital Minority 000 0000 000000 0
Peakdale Molecular Corporation Minority 000 0000 000000 0
Quaker Partners Venture Capital Minority 000 0000 000000 0
Syngenta Ventures Corporate Venture Capital 000 0000 000000 0
To view BioLeap’s complete investors history, request access »